From: Long noncoding RNA SNHG6 mainly functions as a competing endogenous RNA in human tumors
Cancer type | miRNA | 3′–5′ sequence | PBS to SNHG6 | Experimental method | Target protein | References |
---|---|---|---|---|---|---|
Gastric cancer | miR-101-3p | AAGTCAATAGTGTCATGACAT | 12 | Luciferase activity assay, RIP, RNA pull down assay | ZEB1 | Yan et al. [29] |
Breast cancer | miR-26a-5p | TCGGATAGGACCTAATGAACTT | 8 | Luciferase activity assay | MAPK6 | lv et al. [39] |
Glioma | miR-101-3p | AAGTCAATAGTGTCATGACAT | 12 | Luciferase activity assay | NA | Meng et al. [43] |
Colorectal cancer | miR-760 | AGGGGUGUCUGGGUCUCGGC | 7 | Dual luciferase reporter assay | FOXC1 | Zhu et al. [23] |
Hepatocellular carcinoma | miR-26a | CGGATAGGACCTAATGAACTT | 8 | RIP, luciferase reporter assays. | TAK1 | Cao et al. [18] |
Hepatocellular carcinoma | miR-26b | TGGATAGGACTTAATGAACTT | 8 | RIP, luciferase reporter assays. | TAK1 | Cao et al. [18] |
Lung adenocarcinoma | miR-26a-5p | TCGGATAGGACCTAATGAACTT | 8 | Luciferase reporter and RNA pull-down assays | E2F7 | Liang et al. [37] |
Bladder cancer | miR-125b | UCACAAGUCAGGCUCUUGGGAC | 8 | Luciferase reporter gene assay | Snail1/2 and NUAK1 | Wang et al. [42] |
Hepatocellular carcinoma | miR-101-3p | AAGTCAATAGTGTCATGACAT | 9 | Luciferase assay | ZEB1 | Chang et al. [9] |
Hepatocellular carcinoma | miR-1297 | AAGTTCATCATTCCCT | 11 | Luciferase assay | MAT2A and FUS | Guo et al. [20] |
Colorectal cancer | miR-101-3p | NA | NA | qRT-PCR | ZEB1 | |
Colorectal cancer | miR-214-3p | UGACGGACAGACACGGACGACA | 14 | Luciferase reporter assay, RNA pull-down assay, ChIP, RIP | EZH2 | Xu et al. [24] |
Colorectal cancer | miR-26a-5p | CGGATAGGACCTAATGAACTT | 8 | Luciferase reporter assay, RNA pull-down assay, ChIP, RIP | EZH2 | Xu et al. [24] |
Colorectal cancer | miR-26b-5p | TGGATAGGACTTAATGAACTT | 8 | Luciferase reporter assay, RNA pull-down assay, ChIP, RIP | EZH2 | Xu et al. [24] |
Colorectal cancer | miR-181a-5p | TGAGTGGCTGTCGCAACTTACAA | 7 | Luciferase reporter assay | E2F5 | Yu et al. [25] |
Osteocarcinoma | miR-26a-5p | TCGGATAGGACCTAATGAACTT | 8 | Luciferase reporter assay | ULK1 | Zhu et al. [49] |
Colorectal cancer | miR-101-3p | AAGTCAATAGTGTCATGACAT | 13 | Luciferase reporter assay | β-catenin | Shao et al. [12] |
Colorectal cancer | miR-26a-5p | CGGATAGGACCTAATGAACTT | 8 | Dual‑luciferase reporter assay | ULK1 | Wang et al. [10] |
Hepatocellular carcinoma | miR-139-5p | UGACCUCUGUGCACGUGACAUCU | 7 | Dual‑luciferase reporter assay,RIP | SERPINH1 | Wu et al. [17] |
Hepatocellular carcinoma | let-7c-5p | ATGGAG | 6 | Luciferase reporter assay | c-Myc | Chen et al. [19] |
Esophageal squamous cell carcinoma | miR‑186‑5p | UCGGGUUUUCCUCU–UAAGAAAC | 13 | Luciferase reporter assay, RNA Pull‑Down Assay | HIF1α | Du et al. [33] |
Breast cancer | miR-26a-5p | GAUUACUUGAACGAGGCCAC | 8 | Luciferase assay, RNA Pull‑Down Assay,RIP | VASP | Li et al. [27] |
Non-Small Cell Lung Cancer | miR-181d-5p | UGGGUGGCUGUUGUUACUUACAA | 10 | Dual-Luciferase Reporter Assay, RIP | ETS1 | Geng et al. [34] |
Non-Small Cell Lung Cancer | miR-944 | GAGUAGGCUACAUGUUAUUAAA | 13 | Dual-Luciferase Reporter Assay, RIP | ETS1 | Geng et al. [34] |
Non-Small Cell Lung Cancer | miR-490-3p | GUCGUACCUCAGGAGGUCCAAC | 7 | Luciferase reporter assay | RSF1 | Dong et al. [35] |
Non-Small Cell Lung Cancer | miR-101-3p | AAGTCAATAGTGTCATGACAT | 13 | Dual-luciferase reporter assay,RIP | CDYL | Li et al. [36] |